These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 32445881)
21. Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up. Liu F; Cai ZB; Huang JS; Yu WY; Niu HY; Zhang Y; Sui DM; Wang F; Xue LZ; Xu AF Pathog Dis; 2020 Jun; 78(4):. PubMed ID: 32592396 [TBL] [Abstract][Full Text] [Related]
22. A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019. Chen Q; Quan B; Li X; Gao G; Zheng W; Zhang J; Zhang Z; Liu C; Li L; Wang C; Zhang G; Li J; Dai Y; Yang J; Han W J Med Virol; 2020 Jun; 92(6):683-687. PubMed ID: 32162699 [TBL] [Abstract][Full Text] [Related]
23. Of chloroquine and COVID-19. Touret F; de Lamballerie X Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496 [TBL] [Abstract][Full Text] [Related]
24. Ribavirin therapy for severe COVID-19: a retrospective cohort study. Tong S; Su Y; Yu Y; Wu C; Chen J; Wang S; Jiang J Int J Antimicrob Agents; 2020 Sep; 56(3):106114. PubMed ID: 32712334 [TBL] [Abstract][Full Text] [Related]
25. A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019. Wang X; Xie P; Sun G; Zhao M; Deng Z; Zhou Y; Bao S Medicine (Baltimore); 2020 Jul; 99(30):e21402. PubMed ID: 32791753 [TBL] [Abstract][Full Text] [Related]
26. Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series. Fu D; Cao R; Zhao L; Li W; Zhong W; Wen J Crit Care; 2020 Sep; 24(1):578. PubMed ID: 32977854 [No Abstract] [Full Text] [Related]
27. Understanding of COVID-19 based on current evidence. Sun P; Lu X; Xu C; Sun W; Pan B J Med Virol; 2020 Jun; 92(6):548-551. PubMed ID: 32096567 [TBL] [Abstract][Full Text] [Related]
28. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study. He XL; Zhou YY; Fu W; Xue YE; Liang MY; Yang BH; Ma WL; Zhou Q; Chen L; Zhang JC; Wang XR Curr Med Sci; 2021 Dec; 41(6):1096-1104. PubMed ID: 34515914 [TBL] [Abstract][Full Text] [Related]
29. Structural Biology Aids the Research of New Anti-COVID-19 Drugs. Lu J; Liu X Curr Org Synth; 2020; 17(3):162-163. PubMed ID: 32538717 [No Abstract] [Full Text] [Related]
30. The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic. Fox ER; Stolbach AI; Mazer-Amirshahi M J Med Toxicol; 2020 Jul; 16(3):311-313. PubMed ID: 32458230 [No Abstract] [Full Text] [Related]
31. Clinical features and treatment of COVID-19 patients in northeast Chongqing. Wan S; Xiang Y; Fang W; Zheng Y; Li B; Hu Y; Lang C; Huang D; Sun Q; Xiong Y; Huang X; Lv J; Luo Y; Shen L; Yang H; Huang G; Yang R J Med Virol; 2020 Jul; 92(7):797-806. PubMed ID: 32198776 [TBL] [Abstract][Full Text] [Related]
32. Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan. Cheng CY; Lee YL; Chen CP; Lin YC; Liu CE; Liao CH; Cheng SH J Microbiol Immunol Infect; 2020 Jun; 53(3):488-492. PubMed ID: 32331982 [TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics of 54 medical staff with COVID-19: A retrospective study in a single center in Wuhan, China. Chu J; Yang N; Wei Y; Yue H; Zhang F; Zhao J; He L; Sheng G; Chen P; Li G; Wu S; Zhang B; Zhang S; Wang C; Miao X; Li J; Liu W; Zhang H J Med Virol; 2020 Jul; 92(7):807-813. PubMed ID: 32222986 [TBL] [Abstract][Full Text] [Related]
34. Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment. Xin S; Cheng X; Zhu B; Liao X; Yang F; Song L; Shi Y; Guan X; Su R; Wang J; Xing L; Xu X; Jin L; Liu Y; Zhou W; Zhang D; Liang L; Yu Y; Yu R Biomed Pharmacother; 2020 Sep; 129():110500. PubMed ID: 32768975 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience. Kamyshnyi A; Koval H; Kobevko O; Buchynskyi M; Oksenych V; Kainov D; Lyubomirskaya K; Kamyshna I; Potters G; Moshynets O Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108051 [TBL] [Abstract][Full Text] [Related]
36. Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19. Liu L; Shi F; Tu P; Chen C; Zhang M; Li X; Li C Medicine (Baltimore); 2021 Jan; 100(4):e24475. PubMed ID: 33530261 [TBL] [Abstract][Full Text] [Related]
37. Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study. Arabi YM; Shalhoub S; Mandourah Y; Al-Hameed F; Al-Omari A; Al Qasim E; Jose J; Alraddadi B; Almotairi A; Al Khatib K; Abdulmomen A; Qushmaq I; Sindi AA; Mady A; Solaiman O; Al-Raddadi R; Maghrabi K; Ragab A; Al Mekhlafi GA; Balkhy HH; Al Harthy A; Kharaba A; Gramish JA; Al-Aithan AM; Al-Dawood A; Merson L; Hayden FG; Fowler R Clin Infect Dis; 2020 Apr; 70(9):1837-1844. PubMed ID: 31925415 [TBL] [Abstract][Full Text] [Related]
38. Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities. Zhou Q; MacArthur MR; He X; Wei X; Zarin P; Hanna BS; Wang ZH; Xiang X; Fish EN Viruses; 2020 Dec; 13(1):. PubMed ID: 33396578 [TBL] [Abstract][Full Text] [Related]
39. Interferon-α2b induced anemia in severe coronavirus disease 2019 patients: a single centered, retrospective study. Li X; Liu T; Hai X; Li L Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):644-650. PubMed ID: 34698601 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the antiviral effect of Arbidol and Chloroquine in treating COVID-19. Li M; Yu T; Zhu J; Wang Y; Yang Y; Zhao K; Yi Y; He J; Li C; He J Ann Palliat Med; 2021 Mar; 10(3):3307-3312. PubMed ID: 33849115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]